nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—CYP2A6—Fluorouracil—colon cancer	0.298	0.52	CbGbCtD
Formoterol—CYP2C9—Capecitabine—colon cancer	0.173	0.301	CbGbCtD
Formoterol—CYP2C9—Fluorouracil—colon cancer	0.102	0.179	CbGbCtD
Formoterol—Musculoskeletal stiffness—Methotrexate—colon cancer	0.00174	0.00407	CcSEcCtD
Formoterol—Skin discolouration—Methotrexate—colon cancer	0.00173	0.00404	CcSEcCtD
Formoterol—Bone disorder—Methotrexate—colon cancer	0.00173	0.00404	CcSEcCtD
Formoterol—Acute coronary syndrome—Irinotecan—colon cancer	0.00173	0.00404	CcSEcCtD
Formoterol—Myocardial infarction—Irinotecan—colon cancer	0.00172	0.00402	CcSEcCtD
Formoterol—Gastroenteritis—Capecitabine—colon cancer	0.00172	0.00402	CcSEcCtD
Formoterol—Herpes simplex—Methotrexate—colon cancer	0.00169	0.00396	CcSEcCtD
Formoterol—Acute coronary syndrome—Fluorouracil—colon cancer	0.00165	0.00387	CcSEcCtD
Formoterol—Myocardial infarction—Fluorouracil—colon cancer	0.00164	0.00385	CcSEcCtD
Formoterol—Conjunctivitis—Fluorouracil—colon cancer	0.00163	0.00382	CcSEcCtD
Formoterol—Urinary tract infection—Fluorouracil—colon cancer	0.00163	0.00382	CcSEcCtD
Formoterol—Inflammation—Methotrexate—colon cancer	0.00161	0.00377	CcSEcCtD
Formoterol—Atrial fibrillation—Capecitabine—colon cancer	0.00161	0.00376	CcSEcCtD
Formoterol—Urinary tract disorder—Vincristine—colon cancer	0.00159	0.00373	CcSEcCtD
Formoterol—Connective tissue disorder—Vincristine—colon cancer	0.00159	0.00371	CcSEcCtD
Formoterol—Urethral disorder—Vincristine—colon cancer	0.00158	0.00371	CcSEcCtD
Formoterol—Rhinitis—Irinotecan—colon cancer	0.00158	0.00369	CcSEcCtD
Formoterol—Sinusitis—Fluorouracil—colon cancer	0.00157	0.00368	CcSEcCtD
Formoterol—Arthritis—Capecitabine—colon cancer	0.00157	0.00366	CcSEcCtD
Formoterol—Connective tissue disorder—Irinotecan—colon cancer	0.00155	0.00362	CcSEcCtD
Formoterol—Cystitis noninfective—Methotrexate—colon cancer	0.00152	0.00357	CcSEcCtD
Formoterol—Melaena—Methotrexate—colon cancer	0.00152	0.00357	CcSEcCtD
Formoterol—Visual impairment—Irinotecan—colon cancer	0.00152	0.00355	CcSEcCtD
Formoterol—Rhinitis—Fluorouracil—colon cancer	0.00151	0.00353	CcSEcCtD
Formoterol—Cystitis—Methotrexate—colon cancer	0.00151	0.00353	CcSEcCtD
Formoterol—Cardiac disorder—Vincristine—colon cancer	0.0015	0.00351	CcSEcCtD
Formoterol—Pharyngitis—Fluorouracil—colon cancer	0.00149	0.0035	CcSEcCtD
Formoterol—Cardiac disorder—Irinotecan—colon cancer	0.00146	0.00342	CcSEcCtD
Formoterol—Mediastinal disorder—Vincristine—colon cancer	0.00146	0.00341	CcSEcCtD
Formoterol—Immune system disorder—Irinotecan—colon cancer	0.00142	0.00333	CcSEcCtD
Formoterol—Mediastinal disorder—Irinotecan—colon cancer	0.00142	0.00332	CcSEcCtD
Formoterol—Dehydration—Capecitabine—colon cancer	0.00141	0.00331	CcSEcCtD
Formoterol—Mental disorder—Vincristine—colon cancer	0.00141	0.00331	CcSEcCtD
Formoterol—Bladder pain—Methotrexate—colon cancer	0.00141	0.0033	CcSEcCtD
Formoterol—Neoplasm—Methotrexate—colon cancer	0.00141	0.0033	CcSEcCtD
Formoterol—Arrhythmia—Irinotecan—colon cancer	0.0014	0.00329	CcSEcCtD
Formoterol—Dry skin—Capecitabine—colon cancer	0.00139	0.00326	CcSEcCtD
Formoterol—Hypokalaemia—Capecitabine—colon cancer	0.00138	0.00324	CcSEcCtD
Formoterol—Nasopharyngitis—Capecitabine—colon cancer	0.00136	0.00318	CcSEcCtD
Formoterol—Back pain—Vincristine—colon cancer	0.00136	0.00318	CcSEcCtD
Formoterol—Gastritis—Capecitabine—colon cancer	0.00135	0.00315	CcSEcCtD
Formoterol—Arrhythmia—Fluorouracil—colon cancer	0.00135	0.00315	CcSEcCtD
Formoterol—Back pain—Irinotecan—colon cancer	0.00132	0.0031	CcSEcCtD
Formoterol—Muscle spasms—Irinotecan—colon cancer	0.00132	0.00308	CcSEcCtD
Formoterol—Influenza—Capecitabine—colon cancer	0.00131	0.00308	CcSEcCtD
Formoterol—Asthma—Capecitabine—colon cancer	0.00131	0.00308	CcSEcCtD
Formoterol—Bronchospasm—Capecitabine—colon cancer	0.00129	0.00303	CcSEcCtD
Formoterol—Agitation—Vincristine—colon cancer	0.00129	0.00302	CcSEcCtD
Formoterol—Angina pectoris—Capecitabine—colon cancer	0.00128	0.003	CcSEcCtD
Formoterol—Ill-defined disorder—Irinotecan—colon cancer	0.00127	0.00297	CcSEcCtD
Formoterol—Bronchitis—Capecitabine—colon cancer	0.00126	0.00296	CcSEcCtD
Formoterol—Malaise—Irinotecan—colon cancer	0.00123	0.00289	CcSEcCtD
Formoterol—Upper respiratory tract infection—Capecitabine—colon cancer	0.00122	0.00286	CcSEcCtD
Formoterol—Hypertension—Vincristine—colon cancer	0.00121	0.00284	CcSEcCtD
Formoterol—Myalgia—Vincristine—colon cancer	0.0012	0.0028	CcSEcCtD
Formoterol—Cough—Irinotecan—colon cancer	0.00119	0.0028	CcSEcCtD
Formoterol—Hyperglycaemia—Capecitabine—colon cancer	0.00119	0.00278	CcSEcCtD
Formoterol—Hypertension—Irinotecan—colon cancer	0.00118	0.00277	CcSEcCtD
Formoterol—Acute coronary syndrome—Capecitabine—colon cancer	0.00116	0.00271	CcSEcCtD
Formoterol—Discomfort—Irinotecan—colon cancer	0.00115	0.0027	CcSEcCtD
Formoterol—Myocardial infarction—Capecitabine—colon cancer	0.00115	0.00269	CcSEcCtD
Formoterol—Anaphylactic shock—Vincristine—colon cancer	0.00115	0.00269	CcSEcCtD
Formoterol—Oedema—Vincristine—colon cancer	0.00115	0.00269	CcSEcCtD
Formoterol—Infection—Vincristine—colon cancer	0.00114	0.00267	CcSEcCtD
Formoterol—Conjunctivitis—Capecitabine—colon cancer	0.00114	0.00267	CcSEcCtD
Formoterol—Urinary tract infection—Capecitabine—colon cancer	0.00114	0.00267	CcSEcCtD
Formoterol—Nervous system disorder—Vincristine—colon cancer	0.00112	0.00263	CcSEcCtD
Formoterol—Haematuria—Capecitabine—colon cancer	0.00112	0.00262	CcSEcCtD
Formoterol—Anaphylactic shock—Irinotecan—colon cancer	0.00112	0.00262	CcSEcCtD
Formoterol—Oedema—Irinotecan—colon cancer	0.00112	0.00262	CcSEcCtD
Formoterol—Chest pain—Fluorouracil—colon cancer	0.00112	0.00261	CcSEcCtD
Formoterol—Myalgia—Fluorouracil—colon cancer	0.00112	0.00261	CcSEcCtD
Formoterol—Infection—Irinotecan—colon cancer	0.00111	0.0026	CcSEcCtD
Formoterol—Discomfort—Fluorouracil—colon cancer	0.0011	0.00258	CcSEcCtD
Formoterol—Nervous system disorder—Irinotecan—colon cancer	0.0011	0.00257	CcSEcCtD
Formoterol—Hypotension—Vincristine—colon cancer	0.00107	0.00251	CcSEcCtD
Formoterol—Oedema—Fluorouracil—colon cancer	0.00107	0.00251	CcSEcCtD
Formoterol—Anaphylactic shock—Fluorouracil—colon cancer	0.00107	0.00251	CcSEcCtD
Formoterol—Infection—Fluorouracil—colon cancer	0.00106	0.00249	CcSEcCtD
Formoterol—Rhinitis—Capecitabine—colon cancer	0.00105	0.00247	CcSEcCtD
Formoterol—Nervous system disorder—Fluorouracil—colon cancer	0.00105	0.00246	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00105	0.00245	CcSEcCtD
Formoterol—Pharyngitis—Capecitabine—colon cancer	0.00104	0.00245	CcSEcCtD
Formoterol—Tachycardia—Fluorouracil—colon cancer	0.00104	0.00244	CcSEcCtD
Formoterol—Hypotension—Irinotecan—colon cancer	0.00104	0.00244	CcSEcCtD
Formoterol—Urinary tract disorder—Capecitabine—colon cancer	0.00104	0.00243	CcSEcCtD
Formoterol—Insomnia—Vincristine—colon cancer	0.00104	0.00243	CcSEcCtD
Formoterol—Oedema peripheral—Capecitabine—colon cancer	0.00104	0.00243	CcSEcCtD
Formoterol—Connective tissue disorder—Capecitabine—colon cancer	0.00103	0.00242	CcSEcCtD
Formoterol—Urethral disorder—Capecitabine—colon cancer	0.00103	0.00242	CcSEcCtD
Formoterol—Visual impairment—Capecitabine—colon cancer	0.00101	0.00237	CcSEcCtD
Formoterol—Insomnia—Irinotecan—colon cancer	0.00101	0.00237	CcSEcCtD
Formoterol—Hypotension—Fluorouracil—colon cancer	0.001	0.00234	CcSEcCtD
Formoterol—Dyspnoea—Irinotecan—colon cancer	0.000996	0.00233	CcSEcCtD
Formoterol—Somnolence—Irinotecan—colon cancer	0.000993	0.00233	CcSEcCtD
Formoterol—Gastrointestinal disorder—Vincristine—colon cancer	0.00099	0.00232	CcSEcCtD
Formoterol—Fatigue—Vincristine—colon cancer	0.000989	0.00232	CcSEcCtD
Formoterol—Dyspepsia—Irinotecan—colon cancer	0.000983	0.0023	CcSEcCtD
Formoterol—Pain—Vincristine—colon cancer	0.000981	0.0023	CcSEcCtD
Formoterol—Constipation—Vincristine—colon cancer	0.000981	0.0023	CcSEcCtD
Formoterol—Asthma—Methotrexate—colon cancer	0.000979	0.00229	CcSEcCtD
Formoterol—Cardiac disorder—Capecitabine—colon cancer	0.000977	0.00229	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000975	0.00228	CcSEcCtD
Formoterol—Insomnia—Fluorouracil—colon cancer	0.000968	0.00227	CcSEcCtD
Formoterol—Gastrointestinal disorder—Irinotecan—colon cancer	0.000964	0.00226	CcSEcCtD
Formoterol—Fatigue—Irinotecan—colon cancer	0.000963	0.00226	CcSEcCtD
Formoterol—Pain—Irinotecan—colon cancer	0.000955	0.00224	CcSEcCtD
Formoterol—Constipation—Irinotecan—colon cancer	0.000955	0.00224	CcSEcCtD
Formoterol—Dyspnoea—Fluorouracil—colon cancer	0.000954	0.00223	CcSEcCtD
Formoterol—Somnolence—Fluorouracil—colon cancer	0.000951	0.00223	CcSEcCtD
Formoterol—Immune system disorder—Capecitabine—colon cancer	0.00095	0.00223	CcSEcCtD
Formoterol—Mediastinal disorder—Capecitabine—colon cancer	0.000948	0.00222	CcSEcCtD
Formoterol—Dyspepsia—Fluorouracil—colon cancer	0.000942	0.00221	CcSEcCtD
Formoterol—Arrhythmia—Capecitabine—colon cancer	0.00094	0.0022	CcSEcCtD
Formoterol—Gastrointestinal pain—Vincristine—colon cancer	0.000938	0.0022	CcSEcCtD
Formoterol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000924	0.00216	CcSEcCtD
Formoterol—Mental disorder—Capecitabine—colon cancer	0.000922	0.00216	CcSEcCtD
Formoterol—Feeling abnormal—Irinotecan—colon cancer	0.00092	0.00216	CcSEcCtD
Formoterol—Malnutrition—Capecitabine—colon cancer	0.000916	0.00214	CcSEcCtD
Formoterol—Pain—Fluorouracil—colon cancer	0.000915	0.00214	CcSEcCtD
Formoterol—Gastrointestinal pain—Irinotecan—colon cancer	0.000913	0.00214	CcSEcCtD
Formoterol—Upper respiratory tract infection—Methotrexate—colon cancer	0.00091	0.00213	CcSEcCtD
Formoterol—Abdominal pain—Vincristine—colon cancer	0.000907	0.00212	CcSEcCtD
Formoterol—Body temperature increased—Vincristine—colon cancer	0.000907	0.00212	CcSEcCtD
Formoterol—Dysgeusia—Capecitabine—colon cancer	0.000897	0.0021	CcSEcCtD
Formoterol—Back pain—Capecitabine—colon cancer	0.000886	0.00207	CcSEcCtD
Formoterol—Abdominal pain—Irinotecan—colon cancer	0.000883	0.00207	CcSEcCtD
Formoterol—Body temperature increased—Irinotecan—colon cancer	0.000883	0.00207	CcSEcCtD
Formoterol—Feeling abnormal—Fluorouracil—colon cancer	0.000882	0.00206	CcSEcCtD
Formoterol—Muscle spasms—Capecitabine—colon cancer	0.000881	0.00206	CcSEcCtD
Formoterol—Tremor—Capecitabine—colon cancer	0.000858	0.00201	CcSEcCtD
Formoterol—Ill-defined disorder—Capecitabine—colon cancer	0.00085	0.00199	CcSEcCtD
Formoterol—Urticaria—Fluorouracil—colon cancer	0.00085	0.00199	CcSEcCtD
Formoterol—Conjunctivitis—Methotrexate—colon cancer	0.000848	0.00199	CcSEcCtD
Formoterol—Body temperature increased—Fluorouracil—colon cancer	0.000846	0.00198	CcSEcCtD
Formoterol—Hypersensitivity—Vincristine—colon cancer	0.000845	0.00198	CcSEcCtD
Formoterol—Haematuria—Methotrexate—colon cancer	0.000832	0.00195	CcSEcCtD
Formoterol—Malaise—Capecitabine—colon cancer	0.000826	0.00193	CcSEcCtD
Formoterol—Hypersensitivity—Irinotecan—colon cancer	0.000823	0.00193	CcSEcCtD
Formoterol—Asthenia—Vincristine—colon cancer	0.000823	0.00193	CcSEcCtD
Formoterol—Palpitations—Capecitabine—colon cancer	0.00081	0.0019	CcSEcCtD
Formoterol—Asthenia—Irinotecan—colon cancer	0.000801	0.00188	CcSEcCtD
Formoterol—Cough—Capecitabine—colon cancer	0.000799	0.00187	CcSEcCtD
Formoterol—Hypertension—Capecitabine—colon cancer	0.000791	0.00185	CcSEcCtD
Formoterol—Hypersensitivity—Fluorouracil—colon cancer	0.000788	0.00185	CcSEcCtD
Formoterol—Diarrhoea—Vincristine—colon cancer	0.000785	0.00184	CcSEcCtD
Formoterol—Chest pain—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Formoterol—Myalgia—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Formoterol—Arthralgia—Capecitabine—colon cancer	0.00078	0.00183	CcSEcCtD
Formoterol—Pharyngitis—Methotrexate—colon cancer	0.000777	0.00182	CcSEcCtD
Formoterol—Anxiety—Capecitabine—colon cancer	0.000777	0.00182	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000775	0.00181	CcSEcCtD
Formoterol—Urinary tract disorder—Methotrexate—colon cancer	0.000774	0.00181	CcSEcCtD
Formoterol—Discomfort—Capecitabine—colon cancer	0.000771	0.0018	CcSEcCtD
Formoterol—Urethral disorder—Methotrexate—colon cancer	0.000768	0.0018	CcSEcCtD
Formoterol—Diarrhoea—Irinotecan—colon cancer	0.000764	0.00179	CcSEcCtD
Formoterol—Dry mouth—Capecitabine—colon cancer	0.000763	0.00179	CcSEcCtD
Formoterol—Dizziness—Vincristine—colon cancer	0.000758	0.00178	CcSEcCtD
Formoterol—Pruritus—Fluorouracil—colon cancer	0.000757	0.00177	CcSEcCtD
Formoterol—Visual impairment—Methotrexate—colon cancer	0.000755	0.00177	CcSEcCtD
Formoterol—Oedema—Capecitabine—colon cancer	0.000748	0.00175	CcSEcCtD
Formoterol—Infection—Capecitabine—colon cancer	0.000743	0.00174	CcSEcCtD
Formoterol—Dizziness—Irinotecan—colon cancer	0.000739	0.00173	CcSEcCtD
Formoterol—Nervous system disorder—Capecitabine—colon cancer	0.000733	0.00172	CcSEcCtD
Formoterol—Diarrhoea—Fluorouracil—colon cancer	0.000732	0.00171	CcSEcCtD
Formoterol—Tachycardia—Capecitabine—colon cancer	0.00073	0.00171	CcSEcCtD
Formoterol—Vomiting—Vincristine—colon cancer	0.000729	0.00171	CcSEcCtD
Formoterol—Cardiac disorder—Methotrexate—colon cancer	0.000727	0.0017	CcSEcCtD
Formoterol—Skin disorder—Capecitabine—colon cancer	0.000726	0.0017	CcSEcCtD
Formoterol—Rash—Vincristine—colon cancer	0.000723	0.00169	CcSEcCtD
Formoterol—Dermatitis—Vincristine—colon cancer	0.000723	0.00169	CcSEcCtD
Formoterol—Headache—Vincristine—colon cancer	0.000719	0.00168	CcSEcCtD
Formoterol—Vomiting—Irinotecan—colon cancer	0.00071	0.00166	CcSEcCtD
Formoterol—Immune system disorder—Methotrexate—colon cancer	0.000708	0.00166	CcSEcCtD
Formoterol—Dizziness—Fluorouracil—colon cancer	0.000707	0.00166	CcSEcCtD
Formoterol—Mediastinal disorder—Methotrexate—colon cancer	0.000706	0.00165	CcSEcCtD
Formoterol—Rash—Irinotecan—colon cancer	0.000704	0.00165	CcSEcCtD
Formoterol—Dermatitis—Irinotecan—colon cancer	0.000704	0.00165	CcSEcCtD
Formoterol—Headache—Irinotecan—colon cancer	0.0007	0.00164	CcSEcCtD
Formoterol—Hypotension—Capecitabine—colon cancer	0.000699	0.00164	CcSEcCtD
Formoterol—Mental disorder—Methotrexate—colon cancer	0.000686	0.00161	CcSEcCtD
Formoterol—Malnutrition—Methotrexate—colon cancer	0.000682	0.0016	CcSEcCtD
Formoterol—Nausea—Vincristine—colon cancer	0.000681	0.0016	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000681	0.00159	CcSEcCtD
Formoterol—Vomiting—Fluorouracil—colon cancer	0.00068	0.00159	CcSEcCtD
Formoterol—Insomnia—Capecitabine—colon cancer	0.000676	0.00158	CcSEcCtD
Formoterol—Rash—Fluorouracil—colon cancer	0.000675	0.00158	CcSEcCtD
Formoterol—Dermatitis—Fluorouracil—colon cancer	0.000674	0.00158	CcSEcCtD
Formoterol—Headache—Fluorouracil—colon cancer	0.00067	0.00157	CcSEcCtD
Formoterol—Dysgeusia—Methotrexate—colon cancer	0.000668	0.00156	CcSEcCtD
Formoterol—Dyspnoea—Capecitabine—colon cancer	0.000667	0.00156	CcSEcCtD
Formoterol—Nausea—Irinotecan—colon cancer	0.000664	0.00155	CcSEcCtD
Formoterol—Back pain—Methotrexate—colon cancer	0.00066	0.00154	CcSEcCtD
Formoterol—Dyspepsia—Capecitabine—colon cancer	0.000658	0.00154	CcSEcCtD
Formoterol—Gastrointestinal disorder—Capecitabine—colon cancer	0.000645	0.00151	CcSEcCtD
Formoterol—Fatigue—Capecitabine—colon cancer	0.000645	0.00151	CcSEcCtD
Formoterol—Pain—Capecitabine—colon cancer	0.000639	0.0015	CcSEcCtD
Formoterol—Constipation—Capecitabine—colon cancer	0.000639	0.0015	CcSEcCtD
Formoterol—Nausea—Fluorouracil—colon cancer	0.000635	0.00149	CcSEcCtD
Formoterol—Ill-defined disorder—Methotrexate—colon cancer	0.000633	0.00148	CcSEcCtD
Formoterol—Feeling abnormal—Capecitabine—colon cancer	0.000616	0.00144	CcSEcCtD
Formoterol—Malaise—Methotrexate—colon cancer	0.000615	0.00144	CcSEcCtD
Formoterol—Gastrointestinal pain—Capecitabine—colon cancer	0.000611	0.00143	CcSEcCtD
Formoterol—Cough—Methotrexate—colon cancer	0.000595	0.00139	CcSEcCtD
Formoterol—Urticaria—Capecitabine—colon cancer	0.000594	0.00139	CcSEcCtD
Formoterol—Abdominal pain—Capecitabine—colon cancer	0.000591	0.00138	CcSEcCtD
Formoterol—Body temperature increased—Capecitabine—colon cancer	0.000591	0.00138	CcSEcCtD
Formoterol—Chest pain—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Formoterol—Arthralgia—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Formoterol—Myalgia—Methotrexate—colon cancer	0.000581	0.00136	CcSEcCtD
Formoterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000577	0.00135	CcSEcCtD
Formoterol—Discomfort—Methotrexate—colon cancer	0.000574	0.00134	CcSEcCtD
Formoterol—Anaphylactic shock—Methotrexate—colon cancer	0.000557	0.0013	CcSEcCtD
Formoterol—Infection—Methotrexate—colon cancer	0.000553	0.00129	CcSEcCtD
Formoterol—Hypersensitivity—Capecitabine—colon cancer	0.000551	0.00129	CcSEcCtD
Formoterol—Nervous system disorder—Methotrexate—colon cancer	0.000546	0.00128	CcSEcCtD
Formoterol—Skin disorder—Methotrexate—colon cancer	0.000541	0.00127	CcSEcCtD
Formoterol—Asthenia—Capecitabine—colon cancer	0.000536	0.00126	CcSEcCtD
Formoterol—Pruritus—Capecitabine—colon cancer	0.000529	0.00124	CcSEcCtD
Formoterol—Hypotension—Methotrexate—colon cancer	0.00052	0.00122	CcSEcCtD
Formoterol—Diarrhoea—Capecitabine—colon cancer	0.000512	0.0012	CcSEcCtD
Formoterol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000507	0.00119	CcSEcCtD
Formoterol—Insomnia—Methotrexate—colon cancer	0.000503	0.00118	CcSEcCtD
Formoterol—Dyspnoea—Methotrexate—colon cancer	0.000496	0.00116	CcSEcCtD
Formoterol—Somnolence—Methotrexate—colon cancer	0.000495	0.00116	CcSEcCtD
Formoterol—Dizziness—Capecitabine—colon cancer	0.000494	0.00116	CcSEcCtD
Formoterol—Dyspepsia—Methotrexate—colon cancer	0.00049	0.00115	CcSEcCtD
Formoterol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00048	0.00113	CcSEcCtD
Formoterol—Fatigue—Methotrexate—colon cancer	0.00048	0.00112	CcSEcCtD
Formoterol—Pain—Methotrexate—colon cancer	0.000476	0.00111	CcSEcCtD
Formoterol—Vomiting—Capecitabine—colon cancer	0.000475	0.00111	CcSEcCtD
Formoterol—Rash—Capecitabine—colon cancer	0.000471	0.0011	CcSEcCtD
Formoterol—Dermatitis—Capecitabine—colon cancer	0.000471	0.0011	CcSEcCtD
Formoterol—Headache—Capecitabine—colon cancer	0.000468	0.0011	CcSEcCtD
Formoterol—Feeling abnormal—Methotrexate—colon cancer	0.000459	0.00107	CcSEcCtD
Formoterol—Gastrointestinal pain—Methotrexate—colon cancer	0.000455	0.00107	CcSEcCtD
Formoterol—Nausea—Capecitabine—colon cancer	0.000444	0.00104	CcSEcCtD
Formoterol—Urticaria—Methotrexate—colon cancer	0.000442	0.00104	CcSEcCtD
Formoterol—Abdominal pain—Methotrexate—colon cancer	0.00044	0.00103	CcSEcCtD
Formoterol—Body temperature increased—Methotrexate—colon cancer	0.00044	0.00103	CcSEcCtD
Formoterol—Hypersensitivity—Methotrexate—colon cancer	0.00041	0.00096	CcSEcCtD
Formoterol—Asthenia—Methotrexate—colon cancer	0.000399	0.000935	CcSEcCtD
Formoterol—Pruritus—Methotrexate—colon cancer	0.000394	0.000922	CcSEcCtD
Formoterol—Diarrhoea—Methotrexate—colon cancer	0.000381	0.000892	CcSEcCtD
Formoterol—Dizziness—Methotrexate—colon cancer	0.000368	0.000862	CcSEcCtD
Formoterol—Vomiting—Methotrexate—colon cancer	0.000354	0.000829	CcSEcCtD
Formoterol—Rash—Methotrexate—colon cancer	0.000351	0.000822	CcSEcCtD
Formoterol—Dermatitis—Methotrexate—colon cancer	0.000351	0.000821	CcSEcCtD
Formoterol—Headache—Methotrexate—colon cancer	0.000349	0.000816	CcSEcCtD
Formoterol—Nausea—Methotrexate—colon cancer	0.000331	0.000774	CcSEcCtD
